Company / Cash per Share
Dyne Therapeutics, Inc. Cash per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.26
FY2024
5-year range
$1.98 / $20.90
FY2020-FY2024
Trend
+115.1%
vs FY2023
Sector context
#48 of 207
Health Care
What the data says
Dyne Therapeutics, Inc.'s cash per share of $4.26 is higher than 77% of companies in the Health Care sector (FY2024). Cash per Share returned to growth in FY2024 after 3 years of decline, reaching $4.26.
Based on SEC 10-K filings.
4.26 in FY2024 with a 5-year CAGR of -6.6%. Top quartile in the Health Care sector.
Improved from $3.09 to $4.26 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +2.6%
- 5-Year CAGR
- -6.6%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 207This company $4.26 Sector average $67.39
▼
-93.7% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 115.1% year-over-year.
- Ranks #48 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.26 | +115.1% |
| FY2023 | $1.98 | -36.1% |
| FY2022 | $3.09 | -21.6% |
| FY2021 | $3.95 | -81.1% |
| FY2020 | $20.90 | +248.9% |
| FY2019 | $5.99 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026